HSD17B3 抗体
(Hydroxysteroid (17-Beta) Dehydrogenase 3 (HSD17B3))
This isoform of 17 beta-hydroxysteroid dehydrogenase is expressed predominantly in the testis and catalyzes the conversion of androstenedione to testosterone. It preferentially uses NADP as cofactor. Deficiency can result in male pseudohermaphroditism with gynecomastia. [provided by RefSeq, Jul 2008].
Recommended next Filters:
您想试用我们的人工智能搜索吗？
22 results
HSD17B3
适用: 人
WB, IHC, FACS, ELISA
宿主: 兔
Polyclonal
unconjugated
Latest Publications for our HSD17B3 抗体
: "A low carbohydrate, high protein diet suppresses intratumoral androgen synthesis and slows castration-resistant prostate tumor growth in mice." in: The Journal of steroid biochemistry and molecular biology, Vol. 150, pp. 35-45, (2015) (PubMed).: "Localization of the androgen-synthesizing enzymes, androgen receptor, and sex steroids in the vagina: possible implications for the treatment of postmenopausal sexual dysfunction." in: The journal of sexual medicine, Vol. 11, Issue 8, pp. 1949-61, (2014) (PubMed).
: "Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo." in: The Journal of steroid biochemistry and molecular biology, Vol. 143, pp. 19-28, (2014) (PubMed).
: "Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer." in: Cancer research, Vol. 68, Issue 15, pp. 6407-15, (2008) (PubMed).
Aliases for HSD17B3 抗体
hydroxysteroid (17-beta) dehydrogenase 3 (Hsd17b3) 抗体hydroxysteroid 17-beta dehydrogenase 3 (HSD17B3) 抗体
EDH17B3 抗体
SDR12C2 抗体
您还需要查找其他产品吗？
You are here:
